Zu den Inhalten springen

Current Research Projects

Project Name:Migraine: Do sufferers benefit from a low-sugar, low-fat, or ketogenic diet?
Contact:PD Dr. Eva Kiesswetter
Duration:March 17, 2026 – September 17, 2027
Collaboration:Department of Neurology, Charité University Medicine Berlin
Funding:IQWIG
Website:https://www.iqwig.de/sich-einbringen/themencheck-medizin/berichte/t25-06.html
Explanation:

Migraine is one of the most common primary headache disorders. It is characterized by recurrent headache attacks, usually on one side of the head and with a throbbing quality. Accompanying symptoms such as nausea and sensitivity to light or sound often occur. In addition to pharmacological approaches, non-pharmacological strategies are also recommended for migraine prevention, e.g., cognitive behavioral therapy, relaxation, and mindfulness techniques. Furthermore, various dietary approaches (low-sugar, low-fat, or ketogenic) are being discussed as potentially effective. 

The aim of the project is to conduct a systematic evaluation of the benefits of these diets in the context of migraine prevention. 

 

 

 

Project Name:NUM Platform for Surveillance and Rapid Response
Contact:Prof. Dr. Jörg Meerpohl 
Duration:July 1, 2025–June 30, 2030
Consortium:Berlin, Göttingen, Cologne, Bonn, Freiburg, Frankfurt, Dresden
Funding:BMBF
Website:https://www.netzwerk-universitaetsmedizin.de/plattformen/num-sar
Description:The “NUM Platform for Surveillance and Rapid Response” (NUM-SAR) strengthens the University Medical Center’s infrastructure for pandemic-related research through knowledge generation, standardized data systems, and comprehensive pathogen surveillance. The research infrastructure at NUM provides important information for pandemic prevention and complements existing laboratory structures of the Public Health Service (ÖGD). This forms the necessary foundation for the effective control and management of future pandemics. NUM SAR collaborates with, among others, the Robert Koch Institute (RKI), public health structures, and other NUM research infrastructures.

 

 

 

Project Name:Revision of the S3 Guideline on the Treatment and Prevention of Obesity in Children and Adolescents (TherapKJA)
Contact:Prof. Dr. Jörg Meerpohl 
Duration:August 1, 2025 – January 31, 2027
Consortium:Uniklinik Ulm
Funding:BMBF / GBA
Website:https://innovationsfonds.g-ba.de/projekte/therapkja.731
Explanation:According to a survey conducted by the Robert Koch Institute between 2014 and 2017, nearly six percent of children and adolescents in Germany are severely overweight, i.e., obese. This percentage continues to rise with age: among adolescents over 14 years of age, the rate is just under eight percent for girls and around nine percent for boys. Obesity is a chronic disease that is already associated with many comorbidities in childhood and adolescence, such as type 2 diabetes, high blood pressure, and psychosocial problems. Children who develop obesity at an early age often retain it into adolescence and adulthood, leading to long-term health and economic burdens.

 

 

 

Project Name:Frenotomy
Contact:Dr. Waldemar Siemens
Duration:October 14, 2025 – April 11, 2027
Collaboration:

UMIT Tyrol (Private University of Health Sciences, Medical Informatics, and Technology), Austria

Medical University of Innsbruck, Austria

Hannover Medical School, Germany

University of Hannover, Germany

Funding:IQWIG
Website:https://www.iqwig.de/sich-einbringen/themencheck-medizin/berichte/t25-02.html 
Explanation:

Tongue-tie in infants can lead to significant breastfeeding problems and pain in the mother’s nipples (“symptomatic ankyloglossia”). A frenotomy, in which the tongue-tie is cut, could lead to more effective breastfeeding and a reduction in pain. 

The aim of the project is to conduct a benefit assessment of frenotomy compared to passive or active control interventions and to also examine costs, cost-effectiveness, and ethical, social, legal, and organizational aspects.

 

 

 

Project Name:WHO ASF - Systematic Reviews on Substitutes for Animal-Based Foods
Contact:Prof. Dr. Lukas Schwingshackl
Duration:June 2025 – December 2025
Collaboration:Institute of Biometry and Epidemiology, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, and German Center for Diabetes Research, partners in Düsseldorf and Munich-Neuherberg
Funding:WHO
Description:Two systematic reviews with meta-analyses are being conducted as part of the development of a planned WHO guideline. The aim is to investigate associations between the substitution of animal-based foods (1) with plant-based foods or (2) with other animal-based foods and the incidence of chronic diseases (cardiovascular diseases, type 2 diabetes, cancer).

 

 

 

Project Name:EvaPLAM – Health and Environmental Assessment of Plant-Based Beverages Compared to Cow’s Milk
Contact:Prof. Dr. Lukas Schwingshackl
Duration:January 1, 2025 – December 31, 2027
Collaboration:

Center of Excellence for Nutrition, Bavaria 

Institute for Nutritional Medicine, Technical University of Munich

Institute for Sustainable Agriculture and Food Economy

Institute for Agricultural Economics, State Institute for Agriculture (LfL)

Funding:Bavarian State Ministry of Food, Agriculture, Forestry, and Tourism
Description:A network meta-analysis of randomized controlled trials examines the effects of various plant-based beverages compared to cow’s milk on metabolic risk markers. A dose-response meta-analysis based on prospective cohort studies analyzes associations between the consumption of plant-based beverages and the development of chronic diseases (e.g., type 2 diabetes, cancer).

 

Project Name:EfANosa - Efficacy of pharmacological and non-pharmacological interventions for the treatment of anorexia nervosa: a network meta-analysis
Contact:Prof. Dr. Lukas Schwingshackl, Dr. Angela Kunzler
Duration:April 1, 2025 – March 31, 2027
Collaboration:

Institute of General Medicine, University Hospital Düsseldorf

Institute of Medical Biometry and Statistics, Medical Center – University of Freiburg

Department of Psychosomatic Medicine and Psychotherapy, Medical Center – University of Freiburg

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, Medical Center – University of Freiburg

Funding:BMBF, DLR Project Management Agency
Explanation:The aim of our network meta-analysis, which includes randomized controlled trials, is to investigate the efficacy and safety of various pharmacological and non-pharmacological interventions in comparison with one another and with control groups, focusing on patient-relevant endpoints in adolescents and adults with anorexia nervosa.

 

Project Name:PrioPEG - Priority-based Group Therapies in Physical and Occupational Therapy
Contact:Dr. Angelika Eisele-Metzger
Duration:January 1, 2025, to December 31, 2027
Collaboration:

Consortium Leader: Dr. Sebastian Voigt-Radloff, Medical Center – University of Freiburg, Section for Health Services Research and Rehabilitation Research (SEVERA)

Participants: Institute for Evidence in Medicine

Funding:GBA - Innovation Committee
Website:

https://innovationsfonds.g-ba.de/projekte/versorgungsforschung/priopeg-prioritaer-umsetzbare-physio-und-ergotherapeutische-gruppentherapien.659

https://priopeg.de/

Description:The goal of the project is to increase the rate of group therapy for two specific indications in physical and occupational therapy, respectively, for which both individual and group therapy are suitable. To this end, a guideline for implementing group therapy will be developed. Patients and therapists will be surveyed about their experiences, and the requirements for the guidelines will be identified. Additionally, findings from effectiveness research and implementation science will be incorporated. A project advisory board with equal representation from patients, health insurance providers, and therapy professionals will oversee the development of the guidelines. Subsequently, these guidelines will be tested in both in-person and digital clinical settings to assess their feasibility and acceptance. Furthermore, a toolbox will be created that establishes verifiable criteria to help identify and prioritize additional group therapies that can be implemented appropriately and with priority in clinical practice.

 

 

Project Name:BipolarLiving - S3 Guideline on the Diagnosis and Treatment of Bipolar Disorders – Living Guideline
Contact:Prof. Dr. Jörg Meerpohl, Valérie Labonté
Duration:October 1, 2024, to September 30, 2027
Collaboration:

Consortium Lead:

Prof. Dr. Andrea Pfennig, Dresden University of Technology, Faculty of Medicine, Department of Psychiatry and Psychotherapy

Collaborating partner:

Institute for Social Medicine, Occupational Medicine, and Public Health (ISAP), Faculty of Medicine, University of Leipzig;

Institute for Evidence in Medicine, Medical Center – University of Freiburg

Funding:GBA - Innovation Committee
Website:innovationsfonds.g-ba.de/projekte/versorgungsforschung/bipolarliving-s3-leitlinie-zur-diagnostik-und-therapie-bipolarer-stoerungen-living-guideline.651
Description:

Bipolar disorders are extremely burdensome for those affected and are often accompanied by significant personal and socioeconomic impairments. Those affected also have a 20 to 30 times higher risk of suicide and a life expectancy reduced by approximately nine years. Early diagnosis and targeted therapy are therefore essential to provide the best possible care for those affected.

To improve care for patients with bipolar disorders, researchers from the BipolarLiving project will update the existing S3 guideline based on the latest scientific findings and develop it into a Living Guideline, which will also be available digitally. Living Guidelines are characterized by the fact that individual recommendations within the guideline are updated as soon as new relevant findings become available, whereas previously, S3 guidelines were updated in their entirety every five years.

 

Project Name:WHO Tropical Oils
Contact:Prof. Dr. Lukas Schwingshackl
Duration:2024–2026
Collaboration:Stellenbosch University
Funding:WHO
Description:The aim of this project is to investigate the health effects of tropical oils using network meta-analyses.

 

Project Name:Digitization of the AWMF Guidelines Registry for an Open, Guideline-Based, Trustworthy Evidence Ecosystem (Dissolve-E)
Contact:Professor Dr. Jörg Meerpohl
Duration:April 1, 2024 to March 31, 2027
Cooperation:

Consortium Lead: Prof. Dr. Ina B. Kopp, Institute for Medical Knowledge Management of the Association of Scientific Medical Societies (AWMF)

Consortium partners: aQua – Institute for Applied Quality Improvement and Research in Healthcare GmbH; Berlin Institute of Health (BIH); Freiburg GRADE Center / Cochrane Germany, represented by the Institute for Evidence in Medicine (IfEM), Medical Center – University of Freiburg; University Medical Center Greifswald, Department of Anesthesiology, Intensive Care, Emergency, and Pain Medicine, Medical Informatics Working Group; German Society for Wound Healing and Wound Treatment (DGfW).

Funding:GBA - Innovation Committee
Website:

https://innovationsfonds.g-ba.de/projekte/versorgungsforschung/dissolve-e-digitalisierung-des-awmf-leitlinienregisters-fuer-ein-offenes-leitlinienbasiertes-vertrauenswuerdiges-evidenz-oekosystem.597

https://www.awmf.org/service/awmf-aktuell/default-621339d7bddc2836aa3ee72e8e84d4e7-18

Explanation:The project aims to improve the usability and, consequently, the use of guidelines for patient care through a digital, interoperable, quality-assured guidelines registry that provides documents for various user groups (including physicians and patients). The digital guideline registry serves as a foundation for empowering patients to participate in medical decision-making and for promoting high-quality, evidence-based healthcare.

 

Project Name:MEDIATE - Methodological guidance for public health evidence synthesis and evidence-based advice
Contact:Professor Dr. Jörg Meerpohl
Duration:March 1, 2024 to February 29, 2028
Collaboration:The MEDIATE consortium comprises four institutions representing several former and current Cochrane Centers as well as World Health Organization Collaborating Centers in Europe: Ludwig Maximilian University of Munich (consortium leader) and the Medical Center – University of Freiburg (Cochrane Germany) in Germany, the University of Applied Sciences Krems (Cochrane Austria) in Austria, and the Norwegian Institute of Public Health (NIPH) in Norway. Together, we possess extensive expertise in methodological approaches, public health, and the field of epidemiological research, prevention, and control of infectious diseases. We are united by long-standing collaboration among ourselves as well as with international organizations and relevant professional networks, and by successfully completed research projects that align with the objectives of this project.
Funding:European Centre for Disease Prevention and Control
Description:MEDIATE supports the ECDC’s efforts to strengthen evidence-based public health in its institutional processes and products. We aim to assist the ECDC in providing clear and ready-to-use methodological guidance and toolkits that strengthen evidence-based approaches in national health institutes across the EU, the European Economic Area, countries with Stabilization and Association Agreements, and elsewhere. We will develop a range of products, including a methodological needs assessment, state-of-the-art reviews of methodological guidance, and a series of practical, user-friendly methodological guides and toolkits. The findings will be published as scientific articles and disseminated through webinars to build a community of experts who implement the toolkits, share experiences with their application, and contribute to methodological advancements over time.

 

Project Name:Pathophysiology and Society:
A Comparative Approach to Glaucoma in Europe and Africa
Contact:Ingrid Töws
Duration:January 1, 2024 – June 30, 2024
Consortium:The project is led by the Eye Clinic at the Medical Center – University of Freiburg. The Institute for Evidence in Medicine, Freiburg, the University of Cape Coast, Ghana, and Kilimanjaro Christian Medical Center, Moshi, Tanzania, are collaborating partners.
Funding:DFG
Description:Glaucoma is the leading cause of irreversible blindness worldwide. Compared to the rest of the world, the prevalence of the disease is higher in sub-Saharan African countries, the age of onset is earlier, and the progression to blindness is more aggressive. Despite the high prevalence and disease burden, up to 9 out of 10 Africans in sub-Saharan Africa who suffer from glaucoma are unaware of their condition. This project aims to initiate an international research collaboration that brings together an international and interdisciplinary team of experts from various fields of clinical glaucoma research (ophthalmology, optometry, vision research, epidemiology, and public health) to investigate the key factors contributing to vision loss in Africa and to determine how these differ from the situation in Europe.

 

Project Name:NMA Substitution
Contact:Prof. Dr. Lukas Schwingshackl
Duration:2023–2025
Collaboration:Institute of Medical Biometry and Statistics, German Diabetes Center, Cochrane Hungary, University of Vienna
Funding:Internal
Description:The aim of this project is to use network meta-analyses to investigate, for the first time, the associations between nutritional supplementation and the incidence of chronic diseases.

 

Project Name:2023 Diagnostic Visual Function Research: Building Capacity in Africa
Contact:Ingrid Töws
Duration:October 1, 2023 – September 30, 2027
Consortium:The project is led by the University of Cape Coast, Ghana. The Eye Clinic at the University Medical Center Freiburg and the Institute for Evidence in Medicine, Freiburg, are cooperation partners
Funding:VELUX Foundation, Switzerland
Description:Visual psychophysics and electrophysiology are fundamental methods for research in the field of vision science. Although sub-Saharan African (SSA) countries account for one-third of the global burden of visual impairment, they lack the equipment and human resources to implement and utilize these research methods. As part of this project, a specialized laboratory will be established at the University of Cape Coast, Ghana, to build research capacity in the fields of visual psychophysics and electrophysiology in SSA. The research laboratory, the first of its kind in SSA, will build and strengthen research and teaching capacities in ophthalmology, optometry, and other fields of the visual sciences by training a doctoral student, local doctoral students, and clinicians from other institutions in SSA.

 

Project Name:National Pandemic Cohort Network - Therapeutic Intervention Platform
Contact:Prof. Dr. Jörg Meerpohl
Duration:July 1, 2023 – June 30, 2025
Cooperation:The project is coordinated by Frankfurt University Hospital and Cologne University Hospital. An additional 21 NUM network partners, as well as 11 other associated partners and NUM infrastructures, are involved in the implementation of the research project
Funding:BMBF
Description:

NAPKON-TIP comprises seven work packages (WP). In WP 1, a cross-cutting working group will be established to address management and communication at the overall project level. In WP 2, research questions will be identified and prioritized. WP 3 aims to continuously stratify disease burdens based on individual data, markers, or other characteristics. WP 4 aims to facilitate ethical and regulatory aspects related to platform studies, while WP 5 establishes a comprehensive service infrastructure for implementation. Furthermore, once the infrastructure is established, WP 6 will address a use case, though the specific research project will be determined later in the process. WP 7 completes the project and develops recruitment strategies for hard-to-reach study populations from emergency, intensive care, and general medicine. The studies conducted within the framework of NAPKPON-TIP are intended to evaluate therapies, which may include medications, devices/software (medical devices), and non-pharmacological interventions.

The Freiburg site is involved in WP 2 of NAPKON-TIP. This work package is coordinated by the Uniklinik Aachen and the Uniklinik Göttingen. As an additional partner within WP 2, the Freiburg site supports the following objectives:

  • Development and implementation of an adaptable and scalable infrastructure for the continuous identification and prioritization of urgent research questions for NAPKON-TIP
  • Systematic identification of evidence gaps through the use of various methods

Continuous prioritization of research questions for the NAPKON-TIP evaluation

 

Project Name: EU Project: Supporting National Vaccination Recommendations
Contact: Prof. Dr. Jörg Meerpohl / Philipp Kapp
Duration: October 1, 2022 – September 30, 2026
Consortium: Institute for Evidence in Medicine (Lead), Partners: Cochrane Centers in Austria (Danube University Krems) and Ireland (University of Galway), Robert Koch Institute (RKI); project management is handled by PricewaterhouseCoopers (PWC) Luxembourg.
Funding: European Health and Digital Executive Agency (HaDEA)

Description:

The main objective of this four-year collaboration is to produce 16 systematic reviews. These reviews are intended to evaluate and summarize the current evidence on vaccines and vaccination programs in EU member states and the EEA. This evidence-based approach will support EU member states in their decisions regarding national vaccination recommendations. In addition to the reviews themselves, the consortium will also develop and conduct online training on methods for assessing the evidence.

The primary beneficiaries of this project are the National Immunization Technical Advisory Groups (NITAGs) in Europe. These groups are composed of independent experts from various disciplines and are integrated into national immunization programs. The NITAGs recommend vaccines as well as the corresponding strategies and programs in individual countries. They are supported by the World Health Organization (WHO).

The consortium began its work in October 2022, and two million euros will be made available over the next four years to promote evidence-based collaboration among the NITAGs in Europe.
Project Name Evaluation of the Concordance and Reliability of Evidence Sets from Randomized Controlled Trials and Cohort Studies in Nutrition Research and Development of New Guidelines for Their Integration into Future Evidence Syntheses
Contact PD Dr. Lukas Schwingshackl, MSc
Duration 2021–2024
Collaboration

Prof. Dr. Holger Schünemann

McMaster University, Hamilton, Ontario, Canada
Funding

German Research Foundation (DFG)

Website: https://gepris.dfg.de/gepris/projekt/459430615

This project will shed new light on the controversial field of nutrition research by comparing the consistency of effect estimates across the endpoint-specific bodies of evidence from randomized controlled trials and cohort studies, thereby helping us understand the reasons for these discrepancies.

Project Name:ERS Guideline Development: Methodological Consultation for the European Respiratory Society
Contact:Dr. Ingrid Töws, Valérie Labonté
Duration:Ongoing
Collaboration:European Respiratory Society
Funding:European Respiratory Society
Websitehttps://channel.ersnet.org/channel-25-guidelines
Description:The methodologists develop high-quality, evidence-based clinical practice guidelines in close collaboration with clinical guideline panels.

 

 

 

Research Projects - Completed

Project Name:Large Language Models to Support the Creation of Systematic Reviews
Contact:Dr. Angelika Eisele-Metzger
Duration:January 1, 2024 – June 30, 2024
Collaboration:

Eye Center, Medical Center – University of Freiburg

Institute of Digitalization in Medicine, Medical Center – University of Freiburg

Funding:Research Commission of the Faculty of Medicine – University of Freiburg
Explanation:The creation of high-quality systematic reviews is typically a time-consuming process. In recent years, efforts to support this process through (semi-)automation and artificial intelligence (AI) have gained increasing importance. Currently, the use of AI systems based on Large Language Models (LLMs) (e.g., “chatbots” such as “ChatGPT” and “Claude”) is being widely discussed in medicine and research. This project investigates the use of LLMs to support the creation of systematic reviews: (1) By applying the LLM system “Claude” to assess the risk of bias in randomized controlled trials, the system’s basic functionality will be tested as a “proof of principle.” (2) A scoping review will also identify the most promising applications of LLMs to support systematic reviews.

 

 

Project Name:Collateral Effects of the Pandemic
Contact:Prof. Dr. Jörg Meerpohl
Duration:September 1, 2023 – August 31, 2024
Consortium:The project is coordinated by Charité in collaboration with Jena University Hospital. Additionally, a total of 25 university hospitals, as well as the Central Institute for Mental Health in Mannheim and the Ruhr University Bochum, Faculty of Psychology, are participating
Funding:BMBF
Website:CollPan | Medical Center – University of Freiburg (uniklinik-freiburg.de)
Description:The CollPan research project, part of the second phase of NUM funding, has the overarching goal of promoting research on the health-related collateral effects of pandemics and identifying factors that enable the surveillance of such effects. The aim of such a surveillance infrastructure is to protect society in general, and particularly vulnerable groups in particular, from negative health-related collateral effects. To achieve this goal, CollPan will, on the one hand, establish a nationwide platform for researching collateral effects within the NUM and beyond, and, on the other hand, build a sustainable interdisciplinary and multidisciplinary research network within the University Medical Center that also includes the leadership and expert committees. These two structures will establish evidence-based and sustainable research on collateral effects in the current pandemic and for future crises. The project launched in September 2023 and will be funded through the NUM until August 2024. Project coordination is handled by Ruhr University Bochum (Prof. Dr. Marie von Lilienfeld-Toal) and Charité – Universitätsmedizin Berlin (Prof. Dr. Malek Bajbouj). A total of 24 NUM sites are participating as partners in the research project. CollPan will support joint data integration, exchange, analysis, and publication with all other NUM projects. Consequently, there are close connections and interactions with all relevant NUM structures and projects, e.g., rapid evidence synthesis/recommendations with PREPARED, cohort presentation and data integration with NUM-RDP or NUKLEUS ECU, and knowledge exchange with coverCHILD, among others.

 

Project Name:PREpardness and PAndemic REsponse in Germany
Contact:Prof. Dr. Jörg Meerpohl
Duration:September 1, 2022 – December 31, 2023
Consortium:All 36 university hospitals in the NUM are participating in PREPARED. The project is coordinated by the Dresden and Göttingen sites. Additionally, approximately 19 non-university partners are involved (e.g., the Robert Koch Institute)
Funding:BMBF
Description:Within PREPARED, the Freiburg site leads Work Package (WP) 1 (“Core Unit PREPARED”) and WP 1.3 (“Rapid Research Prioritization and Initiation”) in collaboration with the Magdeburg site (Prof. Dr. Christian Apfelbacher). This sub-WP aims to develop a concept and cooperation structures for the rapid prioritization, funding, and initiation of research in the field of pandemics in collaboration with national funding agencies (e.g., the Federal Ministry of Health) and NAPKON v2. In addition, the Freiburg site—alongside Munich (Prof. Dr. Eva Rehfuess)—assumes a leadership role in WP 1.5 (“Knowledge Transfer and Communication”), which aims to develop a concept for targeted knowledge transfer and exchange with relevant actors and various stakeholders. In cooperation with the Cologne site (Prof. Dr. Nicole Skoetz) and the Berlin site (Prof. Dr. Claudia Spies, Dr. Anika Müller), the Freiburg site also leads Work Packages WP 6 (“Rapid Evidence Synthesis”) and WP 7 (“Rapid Recommendations for Action”), which aim to design and plan a network of “Centers of Excellence” in Germany. This network is intended to be rapidly activated in the event of a pandemic, a public health emergency, or a health policy challenge, and to both produce evidence syntheses according to international gold standards and support the development of evidence-based (rapid) recommendations for action and guidelines for clinical patient care, policy, and society.

 

Project Name:HTA: “Does a shorter course of antibiotics lead to comparable results as a longer, conventional one?”
Contact:Alexander Benkendorff, Prof. Dr. Jörg Meerpohl
Duration:September 6, 2023 – March 28, 2025
Collaboration:UMIT (Hall/Tyrol, Austria)
Funding:Institute for Quality and Efficiency in Health Care (IQWiG)
Website:https://www.iqwig.de/sich-einbringen/themencheck-medizin/berichte/t23-04.html
Explanation:“Infectious diseases caused by bacteria can be effectively treated with antibiotics. However, taking antibiotics can also cause side effects such as diarrhea or fungal infections. Incorrect or excessive use of antibiotics can also lead to the development of resistance. In this case, standard medications no longer work, and an infection that is otherwise easily treatable can even become life-threatening. Antibiotics are usually taken even after the symptoms of the illness have disappeared. Shorter courses of treatment, however, could be just as effective and offer a way to reduce side effects and counteract resistance.” (Quote, source: IQWIG www.iqwig.de/sich-einbringen/themencheck-medizin/berichte/t23-04.html)

 


Project Name:

BA_SURG - Bariatric Surgery in Patients with Obesity 

and diabetes mellitus: a network meta-analysis - Cochrane Review

Contact:

PD Dr. Lukas Schwingshackl, MSc

Duration:

April 1, 2023 – March 31, 2025

Collaboration:

Cochrane Metabolic and Endocrine Disorders Group

Center for Obesity and Metabolic Surgery, Medical Center – University of Freiburg

Funding:

BMBF, DLR Project Management Agency

Description: The aim of this project is to investigate, for the first time, the long-term effects and risks of bariatric procedures in comparison with one another and with control groups.
Project Name:Transition of Young People with Obesity from Pediatrics to Adult Medicine / TransitADI
Project Leader:PD Dr. Susanna Wiegand (German Obesity Society)
Contact:Prof. Dr. Jörg Meerpohl
Duration:April 1, 2023 – September 30, 2025
Consortium:

  • Charité University Medicine Berlin; SPZ - Pediatric Endocrinology and Diabetology
  • Charité University Medicine Berlin, Institute of Nursing Science
  • Hannover Medical School, Society for Transition Medicine,
  • Medical Center – University of Freiburg, Institute for Evidence in Medicine
Funding:BMBF/GBA
Explanation:

The transition to adulthood is marked by far-reaching physical and psychosocial changes and demands increasing personal responsibility from adolescents. For young people with obesity, these developmental changes pose a particular challenge, as they often experience stigmatization and discrimination due to their condition, and the specific challenges associated with the disease can lead to limitations in planning for the future (e.g., career, relationships). In addition, as they become adults, they must assume responsibility for their own health and navigate a transition within the healthcare system. This transition carries the risk of a disruption in appropriate care, as the range of services in adult medicine is highly fragmented and spread across many specialties (including general medicine, endocrinology, orthopedics, psychosomatics, and rehabilitation medicine). Compounding this issue is the fact that existing guidelines for children and adults are sometimes contradictory, and none of the guidelines address the specific characteristics of adolescence and the transition phase.

To ensure coordinated, multidisciplinary care during the vulnerable life phase from adolescence into young adulthood and to prevent young people from falling through the cracks in the healthcare system, an evidence-based guideline is to be developed that structures and standardizes the treatment of young people with obesity as well as their transition to adult medical care facilities.

 

Project Name: Dissemination Bias in Qualitative Research
Contact: Ingrid Toews
Duration: January 1 to June 1, 2023
Collaboration: Norwegian Institute of Public Health, University of Sheffield,
Bangor University
Funding: Research Commission of the Faculty of Medicine of Freiburg

 

Description:

Qualitative research serves as an important basis for decision-making in healthcare, including for the implementation of evidence-based health measures, and contributes to guidelines and policy decisions. Qualitative evidence syntheses (QES) systematically synthesize qualitative evidence by jointly analyzing and interpreting evidence from similar individual studies. The GRADE-CERQual approach (Confidence in the Evidence from Reviews of Qualitative research) was developed to assess the level of confidence that can be placed in the results of QES. Dissemination bias (DB) describes a systematic distortion of results arising from the systematic non-publication of studies due to the nature of their content. DB potentially weakens confidence in the evidence used for decision-making. Research findings show that approximately 50% of quantitative research remains unpublished after completion, leading to undesirable and negative impacts on health and the healthcare system. In the field of qualitative research, there are virtually no major studies on this topic. This project investigates the extent of non-publication of qualitative studies by tracking the publication status of a cohort of qualitative conference abstracts. The aim is to determine the proportion of published and unpublished studies and to analyze the characteristics associated with subsequent non-publication.

Project Name: LSR-PIRADS
Contact: Alexander Benkendorff, Prof. Dr. Jörg Meerpohl
Duration: August 1, 2022–July 31, 2025
Collaboration: Uniklinik Freiburg, Department of Radiology, PD Dr. Benndorf
Funding: BMBF, DLR Project Management Agency
Description: A comprehensive systematic review and meta-analysis of the diagnostic accuracy of prostate MRI using PI-RADS (Prostate Imaging Reporting and Data System), evaluating its ability to detect prostate cancer
Project Name:

FASD - Fetal Alcohol Spectrum Disorder

Update of the S3 Guideline on the Diagnosis of FASD
Contact: Prof. Dr. Jörg Meerpohl
Duration: May 1, 2022–April 30, 2025
Funding Body /
Collaboration:
Society for Neuropediatrics e.V.
Funding:

Society for Neuropediatrics (Gesellschaft für Neuropädiatrie e.V.) via the Federal Ministry of Education and Research (BMBF),

DLR Project Management Agency
Project Name: Update: Milk - The Latest from Science
Contact: PD Dr. Lukas Schwingshackl, MSc
Duration: 2022–2024
Collaboration:

  • Prof. Hans Hauner: Technical University of Munich
  • Center of Excellence for Nutrition, Bavaria
Funding: Bavarian State Ministry of Food, Agriculture, and Forestry
Description: Using new innovative methods such as network meta-analysis, the effects and associations of milk and dairy products are being investigated with regard to clinically relevant endpoints and intermediate risk factors.
Project Name:

Substitution of animal-based foods with plant-based foods on cardiometabolic health:

a systematic review and meta-analysis of prospective studies

Contact: PD Dr. Lukas Schwingshackl, MSc
Duration: January 1, 2022 – December 31, 2022
Collaboration: German Diabetes Center
Funding: Alpro Foundation
Project Name: Comparison of Oral Nutritional Interventions in Hospitalized Elderly Patients with Malnutrition: Network Meta-Analysis of Individual Patient Data
Contact: PD Dr. Lukas Schwingshackl, MSc
Duration: 2022–2023
Collaboration:

  • Prof. Bernd Richter: Cochrane Metabolic and Endocrine Group
  • Prof. Dr. Kristina Norman: German Institute of Human Nutrition (DIfE) and
    Charité University Medicine Berlin
Funding: Federal Ministry of Education and Research (BMBF)
Description: The aim of our planned Cochrane review is to examine comparative effects based on IPD data and to develop a clinically meaningful ranking of various dietary interventions (e.g., oral nutritional supplements, nutritional counseling, food modification/fortification) compared to various types of control groups regarding patient-relevant endpoints (e.g., quality of life, functional status, all-cause mortality, morbidity) in hospitalized older patients with malnutrition.
Project Name: SURGE-AHEAD - Digital Geriatric Co-Management Using Evidence-Based Geriatric Assessment and Artificial Intelligence in Surgery
Contact: Sebastian Voigt-Radloff (SEVERA), Jörg Meerpohl
Duration: July 1, 2021–June 30, 2024
Collaboration: AGAPLESION Bethesta Clinic Ulm
Funding: DLR Project Management
Website www.gesundheitsforschung-bmbf.de/de/surge-ahead-digitales-geriatrisches-co-management-mit-hilfe-eines-evidenz-basierten-13994.php
Description: The goal of "SurgeAhead" is therefore to improve the quality of care for older patients in surgical departments with the help of digital technologies.
   
   
   
   
 

 

Contact

Julia Stadelmaier

Duration April 2021 – October 2021
Collaboration Institute of Nursing Science, University of Freiburg
Funding Federal Ministry of Education and Research

In this project, the IfEM is supporting the Institute of Nursing Science in conducting a comprehensive literature review (scoping review) to explore and analyze the existing evidence on self-management following solid organ transplantation.

The goal is to develop and test a program to support and promote self-management among people following organ transplantation. Experts and affected individuals will be involved in this process. The research project is funded by the Federal Ministry of Education and Research (BMBF)

Link to the Institute of Nursing Science’s SMART project page

Contact: Prof. Dr. Jörg Meerpohl, Ingrid Töws
Duration: January 15, 2021–January 14, 2022
Collaboration: LMU Munich
Funding: BMBF/FKZ01KA2022
Contact

Dr. Angelika Eisele-Metzger

Duration January 1, 2021 – December 31, 2021
Collaboration

Institute for Exercise Therapy and Exercise-Oriented Prevention and Rehabilitation, German Sport University Cologne

Institute of Medical Biometry and Statistics, Medical Center – University of Freiburg

Institute for Workplace Health Promotion
Funding Federal Ministry of Education and Research

Back pain is widespread and causes a significant degree of disability and high costs worldwide. The workplace offers an important starting point for interventions aimed at preventing back pain. The available interventions are diverse and often include various components, such as exercise combined with education and ergonomic adjustments to the workplace.

The aim of this systematic review is to identify various workplace-based interventions for the prevention of nonspecific back pain and to compare their effects using a network meta-analysis. Where possible, the effects of individual intervention components will also be determined and compared with one another in a component network meta-analysis. Based on the analyses, the interventions will be ranked according to their effectiveness. This should enable the identification of the most promising interventions for the prevention of back pain in workplace settings.

Project Name:

PlanPsy: 

Consulting and accompanying research for a research and development project on plain-language summaries (PLS) of meta-analytically synthesized evidence in psychology
Contact: Claudia Breuer
Duration: July 1, 2021–June 30, 2023
Funding: Leibniz Institute for Psychology (ZPID)
Website:

https://leibniz-psychology.org/forschung/forschungsliteralitaet/plan-psy/

Contact

Prof. Dr. Jörg Meerpohl

Duration

Starting 07/2021 (16 months)

Collaboration

UMIT (Hall/Tyrol, Austria)

Funding

Institute for Quality and Efficiency in Health Care (IQWiG)

Website:

https://www.iqwig.de/sich-einbringen/themencheck-medizin-thema-vorschlagen/hta-berichte/ht21-03.html

This HTA examines the effectiveness of eye exercises for children and adolescents with visual impairments.

Project Name

DEAL - Dynamic Evidence Update for Current Guideline Recommendations

Contact

Prof. Dr. Jörg Meerpohl

Duration

October 1, 2021 – March 30, 2023     

Collaboration

AWMF, ÄZQ

Funding

BMBF/DLR Project Management Agency

Website

https://innovationsfonds.g-ba.de/projekte/versorgungsforschung/deal-dynamische-evidenzaktualisierung-fuer-aktuelle-leitlinienempfehlungen.399

Methodology Guide

Guide to Living Guidelines and Vaccination Recommendations

Project Name NMA_EPA_S: Network meta-analysis on the effectiveness of nutritional intervention strategies in the primary prevention of overweight and obesity in school settings
Contact Prof. Dr. Lukas Schwingshackl
Duration 12 months

Collaborating Partners:

 

1.

Institute for Evidence in Medicine (IfEM), Medical Center – University of Freiburg

2.

Institute of Medical Biometry and Statistics (IMBI), Medical Center – University of Freiburg

3.

Division of Sports and Rehabilitation Medicine, Medical Center Ulm

4.

Science Department, German Nutrition Society (DGE)

5.

Department of Nutritional Sciences, University of Vienna

6.

Center for Teacher Education, University of Vienna

7.

Department of Public Health, Health Services Research, and Health Technology Assessment, UMIT TIROL

8.

Department of Cardiology and Internal Medicine & Department of Human Nutrition, University of Warmia and Mazury

9.

Cochrane Germany Foundation (CDS)

Funding

Federal Ministry of Education and Research

The aim of this project is to use a network meta-analysis (NMA) to compare various dietary intervention strategies that have been evaluated in randomized controlled trials (RCTs) and, based on this, to rank the most effective dietary intervention strategies for the primary prevention of overweight and obesity in school settings.

Contact Prof. Dr. Jörg Meerpohl
Duration September 2020 – March 2021
Collaboration Charité Berlin
Funding Federal Ministry of Education and Research
Website www.netzwerk-universitaetsmedizin.de/projekte/ceo-sys

Background

The traditional systematic review is not ideal for quickly providing up-to-date and reliable decision-making foundations during a pandemic characterized by rapidly evolving research. The CEOsys collaborative project aims to ensure the quality of medical care, support policy decisions, and focus research activities on pandemic response by addressing the most urgent questions through dynamic evidence syntheses and the resulting recommendations for action.

Methods

The CEOsys collaborative project, involving 21 universities and four additional partners, is funded by the BMBF as part of the University Medicine Network. CEOsys is establishing a national evidence ecosystem of human studies on COVID-19. Registered, ongoing, or completed studies on COVID-19 are systematically recorded, and their results are evaluated using standardized criteria. This work provides the foundation for “living,” i.e., regularly updated, evidence syntheses.

CEOsys covers the following COVID-19 topic areas:

  1. Testing and Diagnostics
  2. Outpatient and inpatient care
  3. Intensive care and palliative care
  4. Hospital hygiene
  5. Public health
  6. Mental health

In collaboration with the AWMF-IMWI and the COVID-19 Task Force, recommendations for action are developed based on the findings and communicated to specific target groups. From this, the interdisciplinary CEOsys collaborative project generates recommendations for action for:

  1. clinical practice
  2. public health
  3. the most urgent next steps in research

CEOsys establishes a quality-assured information platform for the scientific community, the healthcare system, the public, and policymakers.

Contact

Prof. Dr. Jörg Meerpohl

Duration

December 2019 – December 2020

Funding

Swiss Cancer League

Website

https://cancerscreeningcommittee.ch/themen/gebaermutterhalskrebs-screening/

 

Prospero Protocol

 

Health Technology Assessment (HTA)

Contact

Prof. Dr. Jörg Meerpohl

Duration

December 2019 – June 2021

Funding

Institute for Quality and Efficiency in Health Care

 

The Health Technology Assessment commissioned by IQWIG identifies and analyzes studies addressing the question of to what extent non-pharmacological treatments can alleviate symptoms of lymphedema.

Website

https://www.themencheck-medizin.iqwig.de/de/hta-berichte/51-ht19-01-lymphoedem-unfoermiges-anschwellen-von-koerperteilen-mit-hautveraenderungen-lassen-sich-durch-nicht-medikamentoese-verfahren-die-symptome-lindern.172.html

Health Technology Assessment (HTA)

Contact Prof. Dr. Lukas Schwingshackl
Duration October 2019 – June 2021
Collaboration International Union of Nutritional Sciences (IUNS)

In this project, the IfEM is supporting the development of an IUNS position paper on dietary fat and the quality of various fats in the prevention of chronic diseases. In this context, the IfEM is conducting scoping reviews that synthesize the evidence from systematic reviews and guidelines on the topic of dietary fat and fat quality.

Contact Prof. Dr. Jörg Meerpohl
Duration July 2019 – June 2020
Collaboration aks gesundheit GmbH
Funding Vorarlberg Health Promotion Fund
Website www.aks.or.at

The overall project aims to improve health literacy regarding childhood vaccinations, thereby supporting informed and self-determined decisions. Through various work packages, the information needs of parents are identified, existing evidence for various childhood vaccinations is reviewed, vaccination decision aids are developed and tested, and finally evaluated.
As a project partner, IfEM is responsible for systematic research and evidence synthesis. Evidence-based dossiers on the efficacy and safety of the rotavirus vaccine, the pneumococcal vaccine, and the hexavalent vaccine are being created. This information forms the basis for the vaccination decision aids.

PEN examines the content, implementation, and effectiveness of policy measures designed to promote healthy eating and physical activity among the population.

Contact

Prof. Dr. Lukas Schwingshackl

Duration

February 2019 – January 2022

Collaboration

28 research institutions from 7 European countries and New Zealand

Funding

BMBF, Reference Number: 01EA1818F

Website

https://www.jpi-pen.eu/

Publication:

https://implementationscience.biomedcentral.com/articles/10.1186/s13012-020-00984-2

 

Noncommunicable diseases such as type 2 diabetes, cardiovascular diseases, cancer, and respiratory diseases account for more than 70% of global deaths. Unhealthy diets and lack of physical activity are the primary risk factors for the development of these diseases. In many European countries, policy measures are being implemented to bring about sustainable changes in dietary and physical activity habits. However, the effects of such measures have not yet been systematically recorded and evaluated.

The European Network on the Effectiveness of Policy Measures for Lifestyle Interventions, or PEN (Policy Evaluation Network), consists of 28 research institutions from 7 European countries and New Zealand. The primary goal is to develop tools for Europe that can be used to evaluate and assess policy measures aimed at promoting healthy eating and physical activity and reducing sedentary behavior.

Risk Perception and Risk Attitudes in Long-Term Opioid Therapy for Outpatients with Chronic, Non-Cancer-Related Pain.

Contact Prof. Dr. Jörg Meerpohl
Duration June 2019 – March 2020
Collaboration Max Planck Society represented by the Max Planck Institute for Human Development
Charité, University Medicine Berlin
Humboldt University of Berlin/Robert Koch Institute Berlin
Funding BMBF, Reference Number 2519AT5001

The increasing inappropriate prescribing of opioids in Germany as long-term therapy for patients with chronic, non-cancer-related pain (CNTS) in outpatient settings and the resulting threat to patient safety calls for a systematic understanding of the reasons behind the sometimes inappropriate prescribing and the associated increased risk of adverse drug events (ADEs). The “ERONA” project aims to close this knowledge gap regarding long-term opioid therapy for CNTS patients in outpatient settings through systematic, experimental research into the risk assessment and risk decisions made by physicians and patients, taking into account how they learn about the risks of drug therapy (description versus experience). Based on this, the project aims to develop intervention strategies designed to reduce identified causes of inadequate medication safety in the context of inappropriate opioid prescribing through facility-independent, online-based educational formats.

GELL-ALTER is creating an evidence map of studies that examine treatment preferences among older patients with multiple chronic conditions.

Contact

Prof. Dr. Jörg Meerpohl

Duration

February 2018 – August 2020

Collaboration

Institute of General Medicine, Johann Wolfgang Goethe University, Frankfurt

Funding

BMBF, Reference Number: 01GL1729

Publications: 

 

 
1.

End-of-life care preferences of older patients with multimorbidity: protocol of a mixed-methods systematic review.
Gonzalez-Gonzalez AI, Schmucker C, Nothacker J, Nguyen TS, Brueckle MS, Blom J, van den Akker M, Röttger K, Wegwarth O, Hoffmann T, Gerlach FM, Straus SE, Meerpohl JJ, Muth C.
BMJ Open. 2020 Jul 6;10(7):e038682. doi: 10.1136/bmjopen-2020-038682.
PMID: 32636289 Free PMC article.

 

2.

Health-related preferences of older patients with multimorbidity: an evidence map.
Gonzalez-Gonzalez AI*, Schmucker C*, Nothacker J, Motschall E, Nguyen TS, Brueckle MS, Blom J, van den Akker M, Röttger K, Wegwarth O, Hoffmann T, Straus SE, Gerlach FM, Meerpohl JJ, Muth C.
BMJ Open. 2019 Dec 15;9(12):e034485. doi: 10.1136/bmjopen-2019-034485.
PMID: 31843855 Free PMC article.
*shared first authorship

 

3. Health-related preferences of older patients with multimorbidity: the protocol for an evidence map.
González-González AI, Schmucker C, Blom J, van den Akker M, Nguyen TS, Nothacker J, Meerpohl JJ, Röttger K, Wegwarth O, Hoffmann T, Straus SE, Gerlach FM, Muth C.
BMJ Open. 2019 Sep 3;9(9):e029724. doi: 10.1136/bmjopen-2019-029724.
PMID: 31481558 Free PMC article.

 

Physician-patient consultations are often complex in older patients with multiple comorbidities due to interactions between diseases and treatments, as well as multifaceted treatment and care needs. To avoid inappropriate care and its consequences, a patient-centered approach that takes patient preferences into account is recommended. However, it is unclear how older patients with multiple chronic conditions prioritize diseases and treatment options and how their preferences are incorporated into the treatment process. The aim of the project is to (1) identify all studies that examined the patient preferences of older patients with multiple chronic conditions in order to map them in an “Evidence Map” (EM) and thereby illustrate evidence clusters (and gaps); (2) conduct a comprehensive systematic review (SR) on one of the evidence clusters. The results will be shared with patient organizations and institutions for general practice advanced training.

Publications:

Registration: Open Science Framework (OSF): DOI 10.17605/OSF.IO/MCRWQ.

This systematic review examines studies on the treatment of rotator cuff tears.

Contact

Prof. Dr. Jörg Meerpohl
Duration May 2018 – December 2019
Collaboration Cochrane Austria
Funding Swiss Medical Board, Bern

The aim of this systematic review is to evaluate the efficacy and safety of surgical interventions compared to no surgical treatment in patients with rotator cuff tears. 

Publications

Christine Schmucker, Viktoria Titscher, Cordula Braun, Irma Klerings, Barbara Nussbaumer-Streit, Gerald Gartlehner, Joerg J Meerpohl. Efficacy and safety of surgical interventions for full-thickness rotator cuff tears. PROSPERO 2018 CRD42018100343

Christine Schmucker, Viktoria Titscher, Cordula Braun, Barbara Nussbaumer-Streit, Gerald Gartlehner, Jörg Meerpohl, Surgical and Non-Surgical Interventions in Complete Rotator Cuff Tears, https://pubmed.ncbi.nlm.nih.gov/33263527/

The quasi-experimental IIT-IMPACT study compares the extent to which the results of research-initiated versus industry-initiated primary studies are (1) published, (2) cited in systematic reviews, and (3) included in clinical guidelines, and are thus available for use in medical care and the planning of further clinical trials.

Contact Prof. Dr. Jörg Meerpohl
Duration January 2017 – December 2019
Funding German Research Foundation (DFG), Reference Number BL 1395/2-1 (http://gepris.dfg.de/gepris/projekt/310365722)

The DFG and BMBF fund high-quality clinical research projects from the academic sector. These investigator-initiated trials (IITs) cover all areas of medical research and often go beyond the scope of industry-sponsored trials (ISTs). IITs are of great importance because they evaluate the efficacy and safety of already approved drugs as well as their use outside the approved indication (off-label use); for example, drugs for the treatment of rare diseases.

To date, however, little is known about the impact of investigator-initiated clinical trials on medical practice. The aim of this research project is therefore to track a predefined number of IITs (including all studies funded by the DFG and BMBF) as well as a corresponding number of ISTs that were completed between 2005 and 2012 in a quasi-experimental study, and to investigate whether their results (1) were published, (2) were cited, particularly in systematic reviews and meta-analyses, and (3) whether they have been incorporated into clinical treatment guidelines and thus into medical practice.

Publications

Initial results were presented as a talk at the 2018 Cochrane Colloquium in Edinburgh: Transparency and completeness of reporting in study registries - a comparative study

MEDIATE aims to improve media and public discourse on diagnostic tests through evidence-based, ethically grounded science communication.

Contact Valérie Labonté
Duration October 2017 – September 2019
Partners Institute of Journalism, Technical University of Dortmund
Funding BMBF, Reference Number: 01GP1771B

The collaborative project is funded by the BMBF program “Discourse Projects on Ethical, Legal, and Social Issues in the Modern Life Sciences.” Using selected diagnostic tests as examples, the project aims to discuss and establish, through dialogue with both young and experienced science journalists and physicians, the necessary content quality criteria for educational information about diagnostic tests, as well as quality criteria for communicating this information to users.

Through a multi-stage process (review of the evidence, quality assessment of reporting, seminars, workshops, and symposia), recommendations regarding quality requirements for educational information for the care process as well as for media reporting will be developed and published. 

 

Publications

Labonté V, Alsaid D, Lang B, Meerpohl JJ. Psychological and social consequences of non-invasive prenatal testing (NIPT): a scoping review. BMC Pregnancy Childbirth. 2019;19(1):385.

Labonté V, Alsaid D, Meerpohl JJ. Psychosocial Consequences of Communicating Results from Non-Invasive Prenatal Testing (NIPT) to Parents: A Scoping Review. Poster. The 26th Cochrane Colloquium; October 16, 2018, Edinburgh, Scotland.

Labonté V, Alsaid D, Meerpohl JJ. Overview of reviews of diagnostic test accuracy for 3 types of non-invasive prenatal diagnostics to detect fetal aneuploidies – protocol. PROSPERO 2018 CRD42018102401.

 

Reports

Labonté V, Gauch J, Alsaid D, Meerpohl JJ. 2019. Overview of reviews: Diagnostic test accuracy of non-invasive prenatal tests (NIPT) to detect fetal aneuploidies.

Labonté V, Gauch J, Meerpohl JJ. 2019. Rapid overview of reviews: Diagnostic test accuracy of HIV self-tests.

Labonté V, Gauch J, Meerpohl JJ. 2019. How can education about diagnostic tests be improved in the physician-patient consultation? – A summary of four expert opinions.

Zähringer J, Labonté V, Meerpohl JJ. 2019. How does media discourse, from the perspective of physicians and medical ethicists, influence the use of diagnostic tests, and is this influence viewed as positive or negative?

 

Popular science articles

Gauch, Labonté, Rüschemeyer 2019. Relieved, anxious, full of regret? The psychological consequences of a non-invasive prenatal diagnostic test (NIPT) for pregnant women. WissenWasWirkt – Cochrane blogs in German.

The cluster-randomized GAP study is evaluating, in Bavarian primary care practices, whether the use of digitally formatted, evidence-based health information during consultations improves the level of knowledge and healthcare-seeking behavior among patients with back pain.

Contact Prof. Dr. Jörg Meerpohl
Duration October 2017 – September 2021
Collaboration University Hospital, Erlangen
BKK Landesverband Bayern, Munich
Technical University, Dortmund
Funding G-BA Innovation Committee, Reference: NVF3_2016-054

Medical treatment that is jointly managed by the patient and physician and tailored to the individual can positively influence the course of the disease. In particular, patients must be empowered to make such decisions with full knowledge of the facts. However, citizens and patients are increasingly seeking information about diseases and treatment options on their own and are overwhelmed by the sheer volume and quality of information available, particularly online. Furthermore, self-research is controversial among the medical community, as self-information can confuse patients and unreliable health information is often not easily recognizable.

The GAP project builds on established European information systems such as NHS Choices and provides patients and physicians with a platform offering evidence-based information on back pain during and after the consultation. The study examines how the level of information among physicians and patients, the assessment of physician-patient communication, and the perceived level of patient involvement differ between groups with and without platform use. Other endpoints being examined include days of work disability caused by back pain and utilization of the healthcare system.

Publications

Brief project description for the Innovation Committee

Lang B, Kunzweiler K, Voigt-Radloff S. Well-informed communication between physician and patient in the digital age—The GAP Project. In: Knieps F, Pfaff H (eds.). BKK Health Report 2017: Digital Work—Digital Health: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft and BKK Dachverband e.V. 2017.

Voigt-Radloff S, Schöpf AC, Boeker M, Frank L, Farin E, Kaier K, Körner M, Wollmann K, Lang B, Meerpohl JJ, Möhler R, Niebling W, Serong J, Lange R, van der Keylen P, Maun A. Well-informed physician-patient communication in consultations on back pain—study protocol of the cluster-randomized GAP trial.

CEBHA+ is a research network dedicated to expanding evidence-based healthcare and public health in Africa.

Contact Prof. Dr. Jörg J. Meerpohl, Dr. Ingrid Töws
Duration December 2016 – November 2021
Collaboration Institute for Medical Informatics, Biometry and Epidemiology, Ludwig Maximilian University, Munich
Funding BMBF, Reference Number: 01KA1609  
Website https://www.cebha-plus.org/  

The overarching goal of the CEBHA+ project is to build sustainable capacities and an infrastructure for evidence-based healthcare in sub-Saharan African countries. This includes primary research, the development of evidence syntheses, as well as evidence-based health policy and its practical implementation. CEBHA+ takes a population-based approach that encompasses both disease prevention and the provision of care.

Publications

Rehfuess EA, Durão S, Kyamanywa P, Meerpohl JJ, Young T, Rohwer A; CEBHA+ consortium. An approach for setting evidence-based and stakeholder-informed research priorities in low- and middle-income countries. Bull World Health Organ. 2016 Apr 1;94(4):297-3

Schmidt BM, Durao S, Toews I, Bavuma CM, Meerpohl JJ, Kredo T: Screening strategies for hypertension: a systematic review protocol. BMJ Open. 2019;9(1):e025043.

Nicol JU, Rohwer A, Young T, Bavuma CM, Meerpohl JJ: Correction to: Integrated models of care for diabetes and hypertension in low- and middle-income countries (LMICs): Protocol for a systematic review. Syst Rev. 2019;8(1):36.

Schmidt BM, Durao S, Toews I, Bavuma CM, Meerpohl JJ, Kredo T. Screening strategies for hypertension (Protocol). Cochrane Database of Systematic Reviews, 2018; Issue 11. Art. No.: CD013212.

Please note that this website has been automatically translated.